SCHRODER ADVEQ
Schroder Adveq was founded in 1997 and is a leading asset manager investing globally in private equity. Pension funds, insurance companies, endowments, family offices and other financial institutions located in Europe, North America and the Asia-Pacific region entrust us with their funds because of our solution-focused approach to private equity.
SCHRODER ADVEQ
Founded:
1997-01-01
Status:
Active
Contact:
+44 20 3219 8811
Email Addresses:
[email protected]
Technology used in webpage:
SPF LetsEncrypt Apple Mobile Web Clips Icon IPv6 JsDelivr Microsoft Azure DNS COVID-19 ASP.NET Cloudflare SSL Varnish
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-09 | Lenskart | Schroder Adveq investment in Series I - Lenskart | 2.2 B INR |
| 2022-06-07 | ImmunOs Therapeutics | Schroder Adveq investment in Series B - ImmunOs Therapeutics | 71 M CHF |
| 2022-02-09 | HAYA Therapeutics | Schroder Adveq investment in Seed Round - HAYA Therapeutics | 5 M USD |
| 2021-08-04 | LEAP India | Schroder Adveq investment in Secondary Market - LEAP India | 34 M USD |
| 2021-06-15 | Alentis Therapeutics | Schroder Adveq investment in Series B - Alentis Therapeutics | 60 M CHF |
| 2021-05-25 | Tessian | Schroder Adveq investment in Series C - Tessian | 65 M USD |
| 2021-05-20 | HAYA Therapeutics | Schroder Adveq investment in Seed Round - HAYA Therapeutics | 18 M CHF |
| 2021-04-26 | Bizongo | Schroder Adveq investment in Series C - Bizongo | 51 M USD |
| 2020-11-12 | Synendos Therapeutics | Schroder Adveq investment in Series A - Synendos Therapeutics | 20 M CHF |
| 2020-11-06 | Memo Therapeutics | Schroder Adveq investment in Series B - Memo Therapeutics | 14 M CHF |
Newest Events participated
Participated in SuperReturn Asia
on 2017-09-25 as sponsor